Kevin Bitterman - 19 Oct 2026 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Oct 2026, 17:33:06 UTC
Prior SEC filing
15 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ommer Chohan, Attorney-in-Fact
Filing notes and source

Key filing fact

Kevin Bitterman filed Form 4 for Disc Medicine, Inc. (IRON) on 21 Oct 2026.

Key facts

  • This page summarizes Kevin Bitterman's Form 4 filing for Disc Medicine, Inc. (IRON).
  • 9 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Oct 2026, 17:33.

Change

  • Previous filing in this sequence was filed on 15 Sep 2026.
  • Current net transaction value: -$3,351,274.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001591747 Primary reporting owner

Bitterman Kevin

Relationship
Director
Address
C/O DISC MEDICINE, INC., 321 ARSENAL STREET, SUITE 101, WATERTOWN
Signature
/s/ Ommer Chohan, Attorney-in-Fact
Signature date
21 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRON transaction

Common Stock

Sale

Transaction value
-$474,782
Shares
-5,937
Change %
-1.9%
Price
$79.97
Shares after
312,929
Date
19 Oct 2026
Ownership
See footnote
Footnotes
F1, F2, F3
IRON transaction

Common Stock

Sale

Transaction value
-$395,212
Shares
-4,942
Change %
-1.6%
Price
$79.97
Shares after
307,288
Date
19 Oct 2026
Ownership
See footnote
Footnotes
F1, F2, F4
IRON transaction

Common Stock

Sale

Transaction value
-$9,197
Shares
-115
Change %
-0.86%
Price
$79.97
Shares after
13,312
Date
19 Oct 2026
Ownership
See footnote
Footnotes
F1, F2, F5
IRON transaction

Common Stock

Sale

Transaction value
-$229,377
Shares
-2,869
Change %
-0.92%
Price
$79.95
Shares after
310,060
Date
20 Oct 2026
Ownership
See footnote
Footnotes
F1, F3, F6
IRON transaction

Common Stock

Sale

Transaction value
-$190,921
Shares
-2,388
Change %
-0.78%
Price
$79.95
Shares after
304,900
Date
20 Oct 2026
Ownership
See footnote
Footnotes
F1, F4, F6
IRON transaction

Common Stock

Sale

Transaction value
-$4,397
Shares
-55
Change %
-0.41%
Price
$79.95
Shares after
13,257
Date
20 Oct 2026
Ownership
See footnote
Footnotes
F1, F5, F6
IRON transaction

Common Stock

Sale

Transaction value
-$1,105,810
Shares
-13,783
Change %
-4.4%
Price
$80.23
Shares after
296,277
Date
21 Oct 2026
Ownership
See footnote
Footnotes
F1, F3, F7
IRON transaction

Common Stock

Sale

Transaction value
-$920,238
Shares
-11,470
Change %
-3.8%
Price
$80.23
Shares after
293,430
Date
21 Oct 2026
Ownership
See footnote
Footnotes
F1, F4, F7
IRON transaction

Common Stock

Sale

Transaction value
-$21,341
Shares
-266
Change %
-2%
Price
$80.23
Shares after
12,991
Date
21 Oct 2026
Ownership
See footnote
Footnotes
F1, F5, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

Shares were sold pursuant to a Rule 10b5-1 trading plan adopted on July 30, 2026.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $80.2476 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

These shares are held by Atlas Venture Opportunity Fund I, L.P. ("Opportunity I"). The general partner of Opportunity I is Atlas Venture Associates Opportunity I, L.P. ("Associates I"). Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. The Reporting Person is a member of Associates I LLC and disclaims beneficial ownership of such securities held by Opportunity I, except to the extent of his pecuniary interest therein, if any.

Footnote F4

These shares are held by Atlas Venture Opportunity Fund II, L.P. ("Opportunity II"). The general partner of Opportunity II is Atlas Venture Associates Opportunity II, L.P. ("Associates II"). Atlas Venture Associates Opportunity II, LLC ("Associates II LLC") is the general partner of Associates II. The Reporting Person is a member of Associates II LLC and disclaims beneficial ownership of such securities held by Opportunity II, except to the extent of his pecuniary interest therein, if any.

Footnote F5

These shares are held by Atlas Venture Fund XII, L.P. ("Atlas XII"). The general partner of Atlas XII is Atlas Venture Associates XII, L.P. ("Associates XII"). Atlas Venture Associates XII, LLC ("Associates XII LLC") is the general partner of Associates XII. The Reporting Person is a member of Associates XII LLC and disclaims beneficial ownership of such securities held by Atlas XII, except to the extent of his pecuniary interest therein, if any.

Footnote F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $80.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.95 to $80.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .